西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2013年
8期
25-26
,共2页
缺血性坏死,足舟状骨%陇中消定膏%中药外敷%双氯芬酸钠
缺血性壞死,足舟狀骨%隴中消定膏%中藥外敷%雙氯芬痠鈉
결혈성배사,족주상골%롱중소정고%중약외부%쌍록분산납
ischemic necrosis,navicular bone%LongZhong XiaoDingGao%TCM for external use%diclofenac sodium emulsion
目的：观察陇中消定膏治疗足舟状骨缺血性坏死的疗效。方法：在限制负重的基础上，将92例足舟状骨缺血性坏死的患者随机分为消定膏治疗组、消定膏+损伤散组、双氯芬酸钠对照组。消定膏治疗组采用中药消定膏外敷，每72小时换药1次；消定膏+损伤散组在消定膏治疗组治疗的基础上口服损伤散0.5 g/次,3次/d；双氯芬酸钠对照组采用双氯芬酸钠乳剂3 g，踝关节下方涂擦，4次/d，20 min/次，治疗12周后观察疗效。结果：3组在改善关节疼痛、僵硬、功能受限等方面与治疗前相比，差异有统计学意义（P＜0.05）,3组治疗后比较，疼痛症状改善无显著性差异（P＞0.05），但消定膏+损伤散组在足功能改善方面效果最佳，消定膏治疗组次之，与双氯芬酸钠乳剂组比较差异有统计学意义。结论：陇中消定膏外敷联合损伤散内服能较好改善足舟状骨缺血性坏死患者的足功能，疗效确切，使用安全方便。
目的：觀察隴中消定膏治療足舟狀骨缺血性壞死的療效。方法：在限製負重的基礎上，將92例足舟狀骨缺血性壞死的患者隨機分為消定膏治療組、消定膏+損傷散組、雙氯芬痠鈉對照組。消定膏治療組採用中藥消定膏外敷，每72小時換藥1次；消定膏+損傷散組在消定膏治療組治療的基礎上口服損傷散0.5 g/次,3次/d；雙氯芬痠鈉對照組採用雙氯芬痠鈉乳劑3 g，踝關節下方塗抆，4次/d，20 min/次，治療12週後觀察療效。結果：3組在改善關節疼痛、僵硬、功能受限等方麵與治療前相比，差異有統計學意義（P＜0.05）,3組治療後比較，疼痛癥狀改善無顯著性差異（P＞0.05），但消定膏+損傷散組在足功能改善方麵效果最佳，消定膏治療組次之，與雙氯芬痠鈉乳劑組比較差異有統計學意義。結論：隴中消定膏外敷聯閤損傷散內服能較好改善足舟狀骨缺血性壞死患者的足功能，療效確切，使用安全方便。
목적：관찰롱중소정고치료족주상골결혈성배사적료효。방법：재한제부중적기출상，장92례족주상골결혈성배사적환자수궤분위소정고치료조、소정고+손상산조、쌍록분산납대조조。소정고치료조채용중약소정고외부，매72소시환약1차；소정고+손상산조재소정고치료조치료적기출상구복손상산0.5 g/차,3차/d；쌍록분산납대조조채용쌍록분산납유제3 g，과관절하방도찰，4차/d，20 min/차，치료12주후관찰료효。결과：3조재개선관절동통、강경、공능수한등방면여치료전상비，차이유통계학의의（P＜0.05）,3조치료후비교，동통증상개선무현저성차이（P＞0.05），단소정고+손상산조재족공능개선방면효과최가，소정고치료조차지，여쌍록분산납유제조비교차이유통계학의의。결론：롱중소정고외부연합손상산내복능교호개선족주상골결혈성배사환자적족공능，료효학절，사용안전방편。
Objective:To explore clinical effects of LongZhong XiaoDingGao in treating ischemic necrosis of tarsal navicular bone. Method:Under the condition of limited weight-bearing, 92 patients were randomized into the treatment group of XiaoDingGao, the group of XiaoDingGao and SunShangSan as well as the control group of di-clofenac sodium emulsion. The treatment group of XiaoDingGao received XiaoDingGao for external use, changing the dressing for 72 hours, besides XiaoDingGao, the group of XiaoDingGao and SunShangSan oral SunShangSan, 0.5g each time, three times per day;and the control group diclofenac sodium emulsion for external use beneath the ankle joint, 3g each time, four times each day, 20 minutes once, clinical efficacy was observed after treating for 12 weeks. Result:Three groups were improved in joint pain, stiffness, joint function limitation and others, the difference among three groups had statistical meaning compared with before treating (P<0.05), the difference in pain improvements had no statistical meaning in the comparison among three groups after treating (P>0.05), but the group of XiaoDing-Gao and SunShangSan demonstrated the best effects in improving feet function, the treatment group of XiaoDingGao the next, the comparisons had statistical meaning compared with the control group of diclofenac sodium emulsion. Conclusion:LongZhong XiaoDingGao for external use and oral SunShangSan could improve feet function of the pa-tients with ischemic necrosis of tarsal navicular bone, the treatment, safe and convenient, could gain definite effects.
